In this video

Share

DEA permits GW Pharma to sell cannabis derived drug, CEO says there is an 'acute need' for the medicine

CNBC's Meg Tirrell reports that the Drug Enforcement Administration recently approved GW Pharma to sell a new cannabis derived drug. The company's CEO, Justin Gover, said that people suffering from epilepsy have been waiting for the medication to be approved.
03:59
Thu, Sep 27 201812:53 PM EDT